Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06591780 · ClinicalTrials.gov registry record · NA

Innovative Multi-Variable Biofeedback for Improving Gait Performance in Individuals With Diabetic Peripheral Neuropathy

A NA study of Diabetes Mellitus and Diabetic Peripheral Neuropathy, sponsored by Florida Institute for Human and Machine Cognition.

Recruiting
Registry status
NA
Development phase
25
Enrollment target
1
Study location

NCT06591780: Recruiting NA study of Diabetes Mellitus and Diabetic Peripheral Neuropathy, sponsored by Florida Institute for Human and Machine Cognition.

NCT06591780 is a NA study of Diabetes Mellitus and Diabetic Peripheral Neuropathy that is actively recruiting participants, run by Florida Institute for Human and Machine Cognition. The registered enrollment target is 25 participants, below the 1,867-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06591780, a NA study of Diabetes Mellitus and Diabetic Peripheral Neuropathy, is actively recruiting participants, sponsored by Florida Institute for Human and Machine Cognition.

RECRUITING
Registry status
NA
Development phase
25 participants
Enrollment target
1
Study location

Study Summary

This study aims to collect data to improve gait function in individuals with Diabetic Peripheral Neuropathy (DPN). The primary goals are to evaluate: * Biomechanical mechanisms contributing to abnormal plantar pressure and propulsion during gait in individuals with DPN * Biofeedback-induced changes in plantar pressure, propulsion, and biomechanics during gait in individuals with DPN The participants will be required to complete * Questionnaires * Clinical examination * 3-Dimensional gait analysis on an instrumented treadmill * Visual and auditory biofeedback on the participant's propulsion and plantar pressure metrics provided by a projector screen during walking

Primary Outcome

Plantar pressure is calculated in kilopascals (kPa) using a force sensor placed between the participant's foot and insole of their shoe. The peak plantar pressure in regions of interest (forefoot) will be calculated.

Interventions

  • OTHER Clinical Evaluation
  • OTHER Plantar Pressure Biofeedback Gait Training
  • OTHER Propulsion Biofeedback Gait Training

Study Locations (1)

Florida

  • Florida Institute for Human and Machine Cognition - Pensacola

Trial Details

FieldValue
Enrollment Target 25 participants
Start Date 2025-10-20
Est. Completion 2027-06-01
Phase NA

What NCT06591780 shows while recruiting

NCT06591780 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 1,867-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (99% lower).

The record links to 2 conditions, with Diabetes Mellitus appearing as the primary indexed condition, and to 3 interventions - of which Clinical Evaluation is the first listed.

NCT06591780 reports a single indexed study location in Florida.

Frequently Asked Questions

What is clinical trial NCT06591780 about?

NCT06591780 is a clinical study titled "Innovative Multi-Variable Biofeedback for Improving Gait Performance in Individuals With Diabetic Peripheral Neuropathy". This study aims to collect data to improve gait function in individuals with Diabetic Peripheral Neuropathy (DPN). The primary goals are to evaluate: * Biomechanical mechanisms contributing to abnormal plantar pressure and propulsion during gait in individuals with DPN * Biofeedback-induced change...

What is the current status of trial NCT06591780?

This trial is currently recruiting. It is a NA study. The enrollment target is 25 participants. The study started on 2025-10-20. Estimated completion is 2027-06-01.

What conditions does trial NCT06591780 study?

This clinical trial studies the following conditions: Diabetes Mellitus, Diabetic Peripheral Neuropathy.

What interventions are being tested in trial NCT06591780?

The interventions under investigation include: Clinical Evaluation (OTHER), Plantar Pressure Biofeedback Gait Training (OTHER), Propulsion Biofeedback Gait Training (OTHER).

Who is sponsoring clinical trial NCT06591780?

This trial is sponsored by Florida Institute for Human and Machine Cognition, which has 7 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06591780 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diabetes Mellitus

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06591780's enrollment target sits among peer trials

25 185th of 208 higher than 22 of 208 other Diabetes Mellitus trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Diabetes Mellitus trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01166854 · 25 participants

    Characterization of Familial Myopathy and Paget Disease of Bone

  • NCT01913106 · 25 participants · Phase 1

    HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer

  • NCT02138669 · 25 participants · NA

    Intacs Prescription Inserts for Keratoconus Patients

  • NCT02174549 · 25 participants · Phase 1

    Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06591780, the US trial registry maintained by the National Library of Medicine. NCT06591780 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.